Assetmark, Inc

SEC CIK: 0001344551
Latest filing: Jul 30, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 61,055
Value: $30.3M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Assetmark, Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	61,055	$30.3M	0.1%	+1,101+1.8%	Added	Holders
Q1 2026	59,954	$26.8M	0.1%	−30,529−33.7%	Reduced	Holders
Q4 2025	90,483	$41.0M	0.1%	+633+0.7%	Added	Holders
Q3 2025	89,850	$35.2M	0.1%	−2,541−2.8%	Reduced	Holders
Q2 2025	92,391	$41.1M	0.1%	+7,094+8.3%	Added	Holders
Q1 2025	85,297	$41.4M	0.1%	+5,432+6.8%	Added	Holders
Q4 2024	79,865	$32.2M	0.1%	−124,206−60.9%	Reduced	Holders
Q3 2024	204,071	$94.9M	0.3%	−176,283−46.3%	Reduced	Holders
Q2 2024	380,354	$178.3M	0.6%	−2,107−0.6%	Reduced	Holders
Q1 2024	382,461	$159.9M	0.5%	−4,937−1.3%	Reduced	Holders
Q4 2023	387,398	$157.6M	0.6%	−117,030−23.2%	Reduced	Holders
Q3 2023	504,428	$175.4M	0.7%	−6,743−1.3%	Reduced	Holders
Q2 2023	511,171	$179.9M	0.7%	−27,668−5.1%	Reduced	Holders
Q1 2023	538,839	$169.8M	0.7%	+137,127+34.1%	Added	Holders
Q4 2022	401,712	$116.0M	0.5%	+13,854+3.6%	Added	Holders
Q3 2022	387,858	$112.3M	0.5%	+380,279+5,017.5%	Added	Holders
Q2 2022	7,579	$2.14M	<0.1%	+2,696+55.2%	Added	Holders
Q1 2022	4,883	$1.27M	<0.1%	+3,062+168.1%	Added	Holders
Q4 2021	1,821	$400.0K	<0.1%	+1,712+1,570.6%	Added	Holders
Q3 2021	109	$20.0K	<0.1%	−39−26.4%	Reduced	Holders
Q2 2021	148	$30.0K	<0.1%	−19−11.4%	Reduced	Holders
Q1 2021	167	$36.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.